Sarepta says its Ebola drug has no ill effects By: MarketWatch October 16, 2014 at 17:27 PM EDT Sarepta Therapeutics says its Ebola drug showed no ill effects after preliminary testing recently on humans. Read More >> Related Stocks: Chimerix Inc Newlink Genetics Cor Sarepta Therapeutics